Показано 0 из 0
Дата |
---|
21:04 |
20.05.2024 |
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
13.96
|
14.66
|
13.86
|
13.80
|
14.25
|
14.21
|
|
|
5 770 652.87
|
150.00
|
13.00
|
14.05
|
14.43
|
13.53
|
14.43
|
13.85
|
|
|
476 979.40
|
304.00
|
13.52
|
15.00
|
14.00
|
13.61
|
14.005
|
13.64
|
|
|
229 199.81
|
127.00
|
13.50
|
15.78
|
14.05
|
13.86
|
14.07
|
14.00
|
|
|
303 622.70
|
181.00
|
13.70
|
15.78
|
13.96
|
13.92
|
14.2019
|
13.95
|
|
|
2 416 716.07
|
897.00
|
13.53
|
15.78
|
14.11
|
13.80
|
14.265
|
13.85
|
|
|
336 690.31
|
225.00
|
5.69
|
15.78
|
14.36
|
13.72
|
14.36
|
13.95
|
|
|
636 137.64
|
315.00
|
13.73
|
15.29
|
14.34
|
13.738
|
14.48
|
14.09
|
|
|
416 511.51
|
253.00
|
13.80
|
15.78
|
14.11
|
13.81
|
14.43
|
14.15
|
|
|
441 033.60
|
339.00
|
13.57
|
15.47
|
14.56
|
13.38
|
14.75
|
14.28
|
|
|
821 168.50
|
497.00
|
Abivax SA, a biotechnology company, develops, markets, and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious diseases in Asia and Latin America.